122 results
Page 5 of 7
8-K
EX-10.1
en3d461o8h
4 Mar 19
Entry into a Material Definitive Agreement
7:05am
424B5
2zjh4x
19 Feb 19
Prospectus supplement for primary offering
8:39am
8-K
EX-99.1
9c520dq88104fsrz
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
8-K
EX-10.1
83e0n90d
4 Jan 19
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-99.1
q8tj8vw3
10 Dec 18
Other Events
2:07pm
8-K
EX-99.1
7h58 4s6oowfn2iepdq
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am
8-K
EX-99.1
xe9sbj857rgki
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
EX-99.1
chept0fc r33j0ny
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
7304dkhjg1f8crs5m9
7 Aug 18
Recro Pharma Reports Second Quarter 2018 Financial Results
7:05am
8-K
EX-99.1
b4vkm8xy8 9ot91
24 May 18
Recro Pharma Receives Complete Response Letter
7:05am
8-K
EX-99.1
bgajc a33bct04yyrwv
9 May 18
Recro Pharma Reports First Quarter 2018 Financial Results
7:01am
8-K
EX-99.1
prv5l2k4a7al 6r
7 May 18
Other Events
9:41am
8-K
EX-99.1
t1a18 w5zs5ec8w
30 Apr 18
Other Events
7:15am